Trial intelligence / Profile preview

PRO-148 vs Systane in Mild to Moderate Dry Eye

NCT01657253Phase 3Completed

Sponsor
Laboratorios Sophia
Start
Nov 2013
Primary completion
Feb 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of PRO-148 in dry eye syndrome (DED), sponsored by Laboratorios Sophia. Started Nov 2013; status: completed.

02

Drugs

PRO-148
03

Conditions

dry eye syndrome (DED)

Beyond the preview

Go deeper on NCT01657253.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01657253.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call